Adverum Biotechnologies, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023: USD -117.12 M

Adverum Biotechnologies, Inc. EBITDA is USD -117.12 M for the Trailing 12 Months (TTM) ending September 30, 2023. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Adverum Biotechnologies, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -143.25 M.
  • Adverum Biotechnologies, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2019 was USD -59.09 M, a -16.94% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)